Navigation Links
Hepatitis B Foundation to Host Annual Crystal Ball Gala
Date:1/14/2014

Doylestown, PA (PRWEB) January 14, 2014

Date: Friday, April 11, 2014

Time: 6 p.m. – 11 p.m.

Location: Warrington Country Club, 1360 Almshouse Road, Warrington, Pa.

Details: The Hepatitis B Foundation, the only national nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide, will host its annual Crystal Ball on Friday, April 11 at Warrington Country Club in Warrington, Pa.

Each year, the Crystal Ball attracts hundreds of leaders from the community, academic institutions, government, health care industry and biotech executives. The gala evening is a fundraiser for the foundation, with all proceeds benefitting its global research, outreach and patient advocacy programs.

This year’s event, the “Cherry Blossom Extravaganza,” includes an evening of dinner, dancing, a silent auction and awards ceremony. The Foundation will honor Dr. Thomas Starzl with the 2014 Baruch S. Blumberg Prize for pioneering the first human liver transplant in 1963.

Foundation leaders also will announce the recipients of the 2014 Community Commitment Award, Teri and Jim Holton, of Doylestown. Both have provided generous support to the Hepatitis B Foundation with Teri serving as chair of the Crystal Ball auction committee for the past four years and making it a tremendous success. In addition, Teri volunteers regularly in the community and her church and Jim supports many local food pantries with donations from Kellogg where he is a senior vice president.

The Hepatitis B Foundation is accepting auction items and sponsorship opportunities are still available. For more information regarding the Crystal Ball, call 215-489-4900.

About the Hepatitis B Foundation: Headquartered in Doylestown, Pa., the Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. To learn more, go to http://www.hepb.org, read our blog at http://wp.hepb.org, follow us on Twitter @HepBFoundation, find us on Facebook at http://www.facebook.com/hepbfoundation or call 215-489-4900.

Contact: Sarah Larson at sarah(at)furiarubel(dot)com or 215-340-0480

Read the full story at http://www.prweb.com/releases/2014/01/prweb11488785.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Study: Higher Hepatitis C Infection During Acupuncture in Asian Americans; polyDNA Recommends That Doctors Prescribe Gene-Eden-VIR against HCV
2. FDA Advisory Committee Recommends Approval of Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C in Adult Patients
3. EU Should Better Prevent Citizens From Hepatitis, Says Liver Patients Organisation ELPA
4. Flagship Biosciences Introduces a New Technique for Measuring Fibrosis in Nonalcoholic Steatohepatitis
5. The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments
6. SeraCare Introduces New Hepatitis C ACCUVERT Seroconversion Panels and Anti-Herpes ACCUSET Performance Panel
7. Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections
8. Janssen Announces Data from Simeprevir in Hepatitis C Patients Will Be Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
9. Comprehensive Global Testing Solutions for Novel Hepatitis C Therapeutics, New Webinar Hosted by Xtalks
10. A Phase IIa Interferon Free Combination Hepatitis C Trial of Simeprevir (TMC435) and TMC647055 Will Commence Shortly
11. Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research ... Inc. has been selected for membership in ARCS Alumni Hall of Fame ...
(Date:10/11/2017)... USA (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s ... take place on 7th and 8th June 2018 in San Francisco, CA. The Summit ... as well as several distinguished CEOs, board directors and government officials from around the ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
Breaking Biology Technology:
(Date:5/16/2017)... 2017   Bridge Patient Portal , an ... MD EMR Systems , an electronic medical record ... have established a partnership to build an interface ... GE Centricity™ products, including Centricity Practice Solution (CPS), ... These new integrations will allow healthcare delivery networks ...
(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
(Date:4/18/2017)... 2017  Socionext Inc., a global expert in SoC-based imaging and ... the M820, which features the company,s hybrid codec technology. A demonstration ... Probe, Inc., will be showcased during the upcoming Medtec Japan at ... the Las Vegas Convention Center April 24-27. ... Click here for an ...
Breaking Biology News(10 mins):